// App-Quantinova.ai

: Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results

Researchers

Presenter

  • Sergey E. Borisov

Principal Investigators

  • Martin Enwerem

  • Rodolfo Romero Leyet

  • Lia DAmbrosio

  • Rosella Centis

  • Giovanni Sotgiu

  • Simon Tiberi

  • Jan-Willem Alffenaar

  • Andrey Maryandyshev

  • Evgeny Belilowski

  • Shashank Ganatra

  • Alena Skrahina

  • Onno Akkerman

  • Alena Aleksa

  • Rohit Amale

  • Janina Artsukevich

  • Judith Bruchfeld

  • Jose A. Caminero

  • Isabel Carpena Martinez

  • Luigi Codecasa

  • Margareth Dalcolmo

  • Justin Denholm

  • Paul Douglas

  • Raquel Duarte

  • Aliasgar Esmail

  • Mohammed Fadul

  • Alex Filippov

  • Lina Davies Forsman

  • Mina Gaga

  • Julia- Amaranta Garcia-Fuertes

  • Jose Maria Garcia-Garcia

  • Gina Gualano

  • Jerker Jonsson

  • Heinke Kunst

  • Jillian S. Lau

  • Barbara Lazaro Mastrapa

  • Jorge Lazaro Teran Troya

  • Selene Manga

  • Katerina Manika

  • Pablo Gonzlez Montaner

  • Jai Mullerpattan

  • Suzette Oelofse

  • Martina Ortelli

  • Domingo Juan Palmero

  • Fabrizio Palmieri

  • Antonella Papalia

  • Apostolos Papavasileiou

  • Marie-Christine Payen

  • Emanuele Pontali

  • Carlos Robalo Cordeiro

  • Tsetan Dorji Sadutshang

  • Tatsiana Sanukevich

  • Varvara Solodovnikova

  • Antonio Spanevello

  • Sonam Topgyal

  • Federica Toscanini

  • Adrian Tramontana

  • Zarir Farokh Udwadia

  • Pietro Viggiani

  • Veronica White

  • Alimuddin Zumla

  • Giovanni Battista Migliori

Medical Centers

  • Moscow Research and Clinical Center for TB Control of the Moscow Government’s Health Department, Russia, Moscow, Russian Federation

  • UCT Lung Institute, Division of Pulmonology, University of Cape Town, Cape Town, South Africa

  • Wits Health Consortium, Johannesburg, South Africa

  • Clinical Unit, District Clinical Specialist Team, Namakwa District, South African National Department of Health , Springbok, South Africa

  • Public Health Consulting Group, Lugano, Switzerland. World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy

  • WHO Collborating Centre for TB and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate , Italy

  • Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Sassari, Italy

  • Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom

  • University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Groningen, Netherlands

  • Northern State Medical University, Arkhangelsk, Russian Federation

  • Moscow Research and Clinical Center for TB Control of the Moscow Government’s Health Department, Russia, Moscow, Russian Federation

  • Department of Respiratory Medicine, P.D. Hinduja National Hospital and MRC, Mumbai, India

  • Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus,

  • University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases & Tuberculosis, Groningen, Tuberculosis Center Beatrixoord, Haren, Netherlands

  • Department of Phthisiology, Grodno State Medical University, GRCC, Grodno, Belarus

  • Unit of Infectious Diseases, Department of Medicine, Solna, Karolinska Institute; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

  • MDR-TB Unit. Tuberculosis Division. International Union against Tuberculosis and Lung Disease (The Union), Paris, France. Pneumology Department, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, Spain

  • Hematology, University Hospital Morales Meseguer, Murcia, Spain

  • TB Reference Centre, Villa Marelli Institute, Milan, Italy

  • Hélio Fraga Reference Center, Fiocruz / MoH, Rio de Janeiro, Brazil

  • Victorian Tuberculosis Program, Melbourne Health; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia

  • Health Policy and Performance Branch, Health Services and Policy Division, Department of Immigration and Border Protection, Sydney, Australia

  • National Reference Centre for MDR-TB, Hospital Centre Vila Nova de Gaia, Department of Pneumology; Public Health Science and Medical Education Department, Faculty of Medicine, University of Porto, Porto, Portugal

  • UCT Lung Institute, Lung Infection and Immunity Unit. Division of Pulmonology, Department of Medicine, University of Cape Town, & Groote Schuur Hospital, Cape , South Africa

  • UCT Lung Institute, Lung Infection and Immunity Unit. Division of Pulmonology, Department of Medicine, University of Cape Town, & Groote Schuur Hospital, Cape , South Africa

  • National TB Surveillance Unit, Public Health Agency, Stockholm, Sweden

  • National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, Greece

  • Bronchiectasis Unit - Respiratory Department, Hospital Universitario Araba, Vitoria-Gasteiz, Spain

  • Tuberculosis Research Programme, SEPAR, Barcelona, Spain

  • Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases ‘L. Spallanzani’, IRCCS, Rome, Italy

  • Department of Oral Medicine, Queen Mary University London, London, United Kingdom

  • Department of Infectious Diseases, Box Hill Hospital, Box Hill, Victoria, Australia

  • Harry Surtie Hospital, Upington, South Africa

  • Department of Infectious Diseases, University National San Antonio Abad Cusco, Cusco, Peru

  • Pulmonary Department, “G. Papanikolaou” Hospital, Aristotle University, Thessaloniki, Greece

  • Pulmonology Division, Municipal Hospital F. J. Munĩz, Buenos Aires, Argentina

  • Pneumology Department, University of Insubria, Varese, Italy

  • Argentinian Society of Respiratory Medicine; Pulmonology Division, Municipal Hospital F. J. Munĩz, Buenos Aires, Argentina

  • AOVV Eugenio Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, Italy

  • Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium

  • Department of Infectious Diseases, Galliera Hospital, Genoa, Italy

  • European Respiratory Society, Lausanne, Switzerland. Coimbra Medical School, Pneumology Department, Coimbra University Hospital, Coimbra, Portugal

  • Tibetan Delek Hospital, Dharamshala, India

  • Pneumology Department, Maugeri Care and Research Institute, Tradate, Italy. Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy

  • University Hospital San Martino, Care and Research Institute, National Institute for Cancer Research, Genoa, Italy

  • Department of Infectious Diseases, Western Hospital, Footscray, Victoria, Australia

  • Department of Respiratory Medicine Barts Health NHS Trust, London, United Kingdom

  • Division of Infection and Immunity, University College London and National Institute for Health Research (NIHR) Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom,

Locations

  • Russia

  • South Africa

  • Italy

  • United Kingdom

  • Netherlands

  • India

  • Belarus

  • Sweden

  • Spain

  • Brazil

  • Australia

  • Portugal

  • Greece

  • Peru

  • Argentina

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Bedaquiline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved